TELYRX HOLDINGS INC.

Pharmaceuticals · Toronto, A6

PharmaceuticalsSEC Form D

TELYRX HOLDINGS INC. filed a Form D with the U.S. Securities and Exchange Commission on April 20, 2026, reporting $12,623,935 raised.

Incorporated in Ontario, Canada and based in Toronto, A6, it operates in the Pharmaceuticals sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that TELYRX HOLDINGS INC. has raised capital from private investors.

Browse more recently funded companies in Pharmaceuticals.

Executives & Directors

  • Vanessa SloweyDirector · Executive Officer
  • John Eric CascioExecutive Officer
  • Adam GardnerExecutive Officer
  • Peter LloydExecutive Officer
  • Rafael JoseExecutive Officer
  • John EusticeExecutive Officer
  • Robert Sean FoleyDirector
  • Michael HandlerDirector
  • Kenneth BernardDirector
  • Andrew BrandtDirector
  • Ransom LangfordDirector

Recently funded in Pharmaceuticals

Other companies that recently filed a Form D

$50.0KRaised

Matthias Therapeutics, LLC

PharmaceuticalsBASKING RIDGE, NJ
May 14, 2026View SEC Form D
$5.3MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 11, 2026View SEC Form D
$2.5MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 8, 2026View SEC Form D
$22.5MRaised

CNS Pharmaceuticals, Inc.

PharmaceuticalsHOUSTON, TX
May 4, 2026View SEC Form D
$4.9MRaised

California Compounding Company, Inc.

PharmaceuticalsLOS ANGELES, CA
May 1, 2026View SEC Form D
TELYRX HOLDINGS INC. raised $12.6M — SEC Form D